SCHEMBL9769183

SCHEMBL9769183

CCCCCCOC(=O)N1CCCC1C=O

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GBA2 Q9HCG7 1/20 0.48
NAAA Q02083 1/20 0.40
DPP4 P27487 3/20 0.40
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
EPHX1 P07099 1/20 0.38
PRKCA P17252 2/20 0.38
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 2/20 0.37
EPHX2 P34913 1/20 0.37
PRCP P42785 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2723323 0.94 LMNA (0.44) GBA2DPP4LMNAPOLBSMN1; SMN2
SCHEMBL32681452 0.94 LMNA (0.44) GBA2DPP4LMNAPOLBSMN1; SMN2
SCHEMBL9275749 0.90 SMN1; SMN2 (0.43) GBA2LMNAPOLBSMN1; SMN2MAPT
SCHEMBL12133179 0.83 RAB9A (0.43) POLBL3MBTL1
SCHEMBL13532420 0.83 RAB9A (0.43) POLBL3MBTL1
SCHEMBL27919865 0.83 HPGD (0.42) GBA2DPP4LMNAPOLBSMN1; SMN2
SCHEMBL6207726 0.81 LMNA (0.40) GBA2DPP4LMNAPOLBSMN1; SMN2
SCHEMBL7771251 0.80 RAB9A (0.59) GBA2LMNASMN1; SMN2L3MBTL1PRCP
SCHEMBL7771246 0.80 RAB9A (0.59) GBA2LMNASMN1; SMN2L3MBTL1PRCP
SCHEMBL9769179 0.79 GBA2 (0.47) GBA2NAAADPP4LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3659609-A1 THERAPEUTIC AGENT FOR FIBROSIS Kyorin Pharmaceutical Co., Ltd. (JP) 2020-06-03 EP disclosed
US-4992534-A Anticarcinogenic agents with better water solubility, low toxicity, absorption and stability OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-12 US disclosed
EP-0303269-A2 2'-Deoxy-5-fluorouridine derivatives, process for preparing the same and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-02-15 EP disclosed